BIONEXUS GENE LAB CORP

BGLCNASDAQ

🏆 #3900 by market capUS Equity

$1.52▼ $0.04 (−2.56%)

Live

1h—

24h▼ 2.6%

7d—

14d—

30d—

1y—

🏦Market Cap

$4M

Small Cap

📈Revenue Growth (YoY)

-67.1%

Declining

📊Gross Margin

12.2%

Thin

💵FCF Margin

31.5%

Strong

⚖️P/S Ratio

1.2x

Cheap

Otter Score

51

Weak

Earnings

Q2 · 2026Reported 2026-05-15

Earnings Per Share

Actual

-0.23

Expected

—

—

—

YoY −666.70%

Revenue

Actual

$22.84K

Expected

—

—

—

YoY −98.90%

Consensus estimates

Recent quarters

Q2 2026

-0.23

—

Q2 2026

-0.53

—

Q4 2025

-0.39

—

Q3 2025

-0.34

—